biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > They told you what they were going to do...

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 23, 2023 9:44pm

121 Views

Post# 35461194

RE:RE:They told you what they were going to do...

Lol. You are a man of little knowledge and obvious motives, TheTrash1234. We chose bankruptcy as the best solution for us for a number of reasons. So, yes, we not only predicted it, we caused it and set the process in motion. It's actually not a misfortune for us. I have no false pride about stuff like that unlike you whose only measurement of life is money.

But that is likely beyond either your understanding or caring.

jd

<< Previous

Bullboard Posts

Next >>

Consumer advocacy law firm investigates Microsoft over X-Box data concerns